Literature DB >> 12894503

Inhibition of cisplatin-induced ATR activity and enhanced sensitivity to cisplatin.

Eugenia M Yazlovitskaya1, Diane L Persons.   

Abstract

Ataxia teleangiectasia mutated (ATM) kinase, ATM-Rad3-related (ATR) kinase and DNA-protein kinase (DNA-PK) belong to a subgroup of protein kinases which play a role in the DNA damage response. In this study, cisplatin was shown to increase ATR activity and decrease ATM and DNA-PK activity. Caffeine, a nonspecific inhibitor of ATR, enhanced the cytotoxic effect of cisplatin, modestly decreased the p53 and p21WAF-1 response to cisplatin, and affected the cdc2-p34/cyclin B1 complex by decreasing both cyclin B1 protein accumulation and cdc2-p34 tyrosine 15 phosphorylation. The observed alteration of several potential ATR downstream targets suggests that inhibition of ATR activity may be one of the mechanism by which caffeine regulates sensitivity to cisplatin.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12894503

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  11 in total

1.  Ataxia telangiectasia and rad3-related kinase contributes to cell cycle arrest and survival after cisplatin but not oxaliplatin.

Authors:  Kriste A Lewis; Kia K Lilly; Evelyn A Reynolds; William P Sullivan; Scott H Kaufmann; William A Cliby
Journal:  Mol Cancer Ther       Date:  2009-04       Impact factor: 6.261

Review 2.  Exploiting replicative stress to treat cancer.

Authors:  Matthias Dobbelstein; Claus Storgaard Sørensen
Journal:  Nat Rev Drug Discov       Date:  2015-05-08       Impact factor: 84.694

3.  Pharmacologic inhibition of ATR and ATM offers clinically important distinctions to enhancing platinum or radiation response in ovarian, endometrial, and cervical cancer cells.

Authors:  Pang-ning Teng; Nicholas W Bateman; Kathleen M Darcy; Chad A Hamilton; George Larry Maxwell; Christopher J Bakkenist; Thomas P Conrads
Journal:  Gynecol Oncol       Date:  2015-01-02       Impact factor: 5.482

4.  Cisplatin sensitizes cancer cells to ionizing radiation via inhibition of nonhomologous end joining.

Authors:  Heather J Boeckman; Kelly S Trego; John J Turchi
Journal:  Mol Cancer Res       Date:  2005-05       Impact factor: 5.852

5.  Cisplatin associated with LY294002 increases cytotoxicity and induces changes in transcript profiles of glioblastoma cells.

Authors:  P O Carminati; F S Donaires; M M Marques; E A Donadi; G A S Passos; E T Sakamoto-Hojo
Journal:  Mol Biol Rep       Date:  2013-11-12       Impact factor: 2.316

6.  Mana-Hox displays anticancer activity against prostate cancer cells through tubulin depolymerization and DNA damage stress.

Authors:  Che-Jen Hsiao; Yunn-Fang Ho; John T-A Hsu; Wei-Ling Chang; Yi-Cheng Chen; Ya-Ching Shen; Ping-Chiang Lyu; Jih-Hwa Guh
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-07-29       Impact factor: 3.000

7.  ATR couples FANCD2 monoubiquitination to the DNA-damage response.

Authors:  Paul R Andreassen; Alan D D'Andrea; Toshiyasu Taniguchi
Journal:  Genes Dev       Date:  2004-08-15       Impact factor: 11.361

8.  A DNA repair pathway-focused score for prediction of outcomes in ovarian cancer treated with platinum-based chemotherapy.

Authors:  Josephine Kang; Alan D D'Andrea; David Kozono
Journal:  J Natl Cancer Inst       Date:  2012-04-13       Impact factor: 13.506

9.  Dynamic modulation of phosphoprotein expression in ovarian cancer xenograft models.

Authors:  Antonis Koussounadis; Simon P Langdon; Inhwa Um; Charlene Kay; Kyle E Francis; David J Harrison; V Anne Smith
Journal:  BMC Cancer       Date:  2016-03-10       Impact factor: 4.430

Review 10.  Targeting DNA Replication Stress for Cancer Therapy.

Authors:  Jun Zhang; Qun Dai; Dongkyoo Park; Xingming Deng
Journal:  Genes (Basel)       Date:  2016-08-19       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.